Despite the disruption Covid-19 has caused across many sectors of the economy, Europe’s burgeoning cannabis industry has continued to make gains. As medical cannabis, consumer CBD and even adult-use markets have continued to develop, so has the pace of investment activity in this nascent industry. A new report titled “The European Cannabis Investment Ecosystem” lifts the lid on investment and deals activity across the continent, revealing an exciting and innovative sector that’s rapidly gaining pace. The report finds that investment into the European cannabis sector has reached an estimated €1.2 billion as of June 2021, with over 50% of publicly recorded deals flowing into healthcare segments and another 40% into wellness opportunities. Investments cover the breadth of the cannabis supply chain; a quarter of reported deals were found to fund formulation and manufacture activities, 17% to fund cultivation and processing, and a further 16% into both brand assets and R&D. Furthermore, the U.K. currently stands at the center of European cannabis investment activity, with over €50 million raised on London’s public markets and over €42 million through private transactions in the first 6 months of 2021 alone.
Mmp News Author, Medical Marijuana Program Connection, 07/28/2021 17:50:00